NASDAQ
OnKure Therapeutics, Inc. (OKUR) has a free cash flow growth of -12.34% as of Friday, May 29, 2026. This represents a 194.61% decrease compared to its 12-month average of 13.05%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.